Neal S. LeLeiko

Neal S. LeLeiko

Auto-generated profile, based on publicly available information

Neal S. LeLeiko

Hasbro Children's Hospital, Providence, Rhode Island

Research Focus & Metrics

Academic Career Length

46Years (1981-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2012 in Genome Biology
Verified
Journal Article
Open access
XMXochitl C Morgan
Xochitl C Morgan
TTTimothy L Tickle
Timothy L Tickle
HSHarry Sokol
Harry Sokol
DGDirk Gevers
Dirk Gevers
KDKathryn L Devaney
Kathryn L Devaney
CHCurtis Huttenhower
Curtis Huttenhower
Background: The inflammatory bowel diseases (IBD) Crohn's disease and ulcerative colitis result from alterations in intestinal microbes and the immune system. However, the precise dysfunctions of microbial metabolism in the gastrointestinal microbiome during IBD remain unclear. We analyzed the microbiota of intestinal biopsies and stool samples from 231 IBD and healthy subjects by 16S gene pyrosequencing and followed up a subset using shotgun metagenomics. Gene and pathway composition were assessed, based on 16S data from phylogenetically-related reference genomes, and associated using sparse multivariate linear modeling with medications, environmental factors, and IBD status. Results: Firmicutes and Enterobacteriaceae abundances were associated with disease status as expected, but also with treatment and subject characteristics. Microbial function, though, was more consistently perturbed than composition, with 12% of analyzed pathways changed compared with 2% of genera. We identified major shifts in oxidative stress pathways, as well as decreased carbohydrate metabolism and amino acid biosynthesis in favor of nutrient transport and uptake. The microbiome of ileal Crohn's disease was notable for increases in virulence and secretion pathways. Conclusions: This inferred functional metagenomic information provides the first insights into community-wide microbial processes and pathways that underpin IBD pathogenesis.

1 January 2012 in Inflammatory Bowel Diseases
Verified
Journal Article
Closed access
PDF file
DTDan Turner
Dan Turner
AGAnne M. Griffiths
Anne M. Griffiths
TWThomas D. Walters
Thomas D. Walters
TSTong Seah
Tong Seah
JMJames Markowitz
James Markowitz
ALArie Levine
Arie Levine

1 August 2009 in Inflammatory Bowel Diseases
Verified
Journal Article
Closed access
PDF file
DTDan Turner
Dan Turner
JHJeffrey Hyams
Jeffrey Hyams
JMJames Markowitz
James Markowitz
TLTrudy Lerer
Trudy Lerer
DMDavid R Mack
David R Mack
PGPediatric IBD Collaborative Research Group
Pediatric IBD Collaborative Research Group

1 February 2014 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
TWThomas D. Walters
Thomas D. Walters
MKMi-Ok Kim
Mi-Ok Kim
LDLee A. Denson
Lee A. Denson
AGAnne M. Griffiths
Anne M. Griffiths
MDMarla Dubinsky
Marla Dubinsky
JHJeffrey S. Hyams
Jeffrey S. Hyams

1 October 2012 in Inflammatory Bowel Diseases
Verified
Journal Article
Open access
PDF file
SMSonia Michail
Sonia Michail
MDMatthew Durbin
Matthew Durbin
DTDan Turner
Dan Turner
AGAnne M. Griffiths
Anne M. Griffiths
DMDavid R. Mack
David R. Mack
EWEytan Wine
Eytan Wine
Background. Although the role of microbes in disease pathogenesis is well established, data describing the variability of the vast microbiome in children diagno

1 June 2010 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
DTDan Turner
Dan Turner
DMDavid Mack
David Mack
NLNeal Leleiko
Neal Leleiko
TWThomas D. Walters
Thomas D. Walters
KUKrista Uusoue
Krista Uusoue
AGAnne M. Griffiths
Anne M. Griffiths